Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.

Autor: Van Neste L; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands., Hendriks RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Dijkstra S; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Trooskens G; MDxHealth BV, Nijmegen, The Netherlands., Cornel EB; Department of Urology, ZGT Hospital, Hengelo, The Netherlands., Jannink SA; MDxHealth BV, Nijmegen, The Netherlands., de Jong H; MDxHealth BV, Nijmegen, The Netherlands., Hessels D; MDxHealth BV, Nijmegen, The Netherlands., Smit FP; MDxHealth BV, Nijmegen, The Netherlands., Melchers WJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands., Leyten GH; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Urology, AMC University Medical Centre, Amsterdam, The Netherlands., de Reijke TM; Department of Urology, AMC University Medical Centre, Amsterdam, The Netherlands., Vergunst H; Department of Urology, CWZ Hospital, Nijmegen, The Netherlands., Kil P; Department of Urology, St. Elisabeth Hospital, Tilburg, The Netherlands., Knipscheer BC; Department of Urology, Scheper Hospital, Emmen, The Netherlands., Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Mulders PF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Van Criekinge W; Department of Mathematical Modelling, Statistics and Bioinformatics, Ghent University, Ghent, Belgium., Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: jack.schalken@radboudumc.nl.

Publikováno v: European urology [Eur Urol] 2016 Nov; Vol. 70 (5), pp. 740-748. Date of Electronic Publication: 2016 Apr 20.

Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.

Autor: Leyten GH; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands., Hessels D; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands., Smit FP; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands., Jannink SA; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands., de Jong H; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands., Melchers WJ; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands., Cornel EB; ZGT Hospital, Department of Urology, Hengelo, the Netherlands., de Reijke TM; AMC University Medical Centre, Department of Urology, Amsterdam, the Netherlands., Vergunst H; CWZ Hospital, Department of Urology, Nijmegen, the Netherlands., Kil P; St Elisabeth Hospital, Department of Urology, Tilburg, the Netherlands., Knipscheer BC; Scheper Hospital, Department of Urology, Emmen, the Netherlands., Hulsbergen-van de Kaa CA; Radboud University Nijmegen Medical Centre, Department of Pathology, Nijmegen, the Netherlands., Mulders PF; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands., van Oort IM; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands., Schalken JA; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands. jack.schalken@radboudumc.nl.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Jul 01; Vol. 21 (13), pp. 3061-70. Date of Electronic Publication: 2015 Mar 18.

Prostate cancer biomarker profiles in urinary sediments and exosomes.

Autor: Dijkstra S; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Birker IL; Department of Urology, Academic Medical Center University Hospital, Amsterdam, The Netherlands., Smit FP; Department of Research and Development, NovioGendix, Nijmegen, The Netherlands., Leyten GH; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., de Reijke TM; Department of Urology, Academic Medical Center University Hospital, Amsterdam, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Mulders PF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Jannink SA; Department of Research and Development, NovioGendix, Nijmegen, The Netherlands., Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Research and Development, NovioGendix, Nijmegen, The Netherlands. Electronic address: jack.schalken@radboudumc.nl.

Publikováno v: The Journal of urology [J Urol] 2014 Apr; Vol. 191 (4), pp. 1132-8. Date of Electronic Publication: 2013 Nov 07.

Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients.

Autor: Verhaegh GW; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., de Jong AS, Smit FP, Jannink SA, Melchers WJ, Schalken JA

Publikováno v: The Prostate [Prostate] 2011 Mar 01; Vol. 71 (4), pp. 415-20. Date of Electronic Publication: 2010 Sep 28.

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer.

Autor: Hessels D; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands., van Gils MP, van Hooij O, Jannink SA, Witjes JA, Verhaegh GW, Schalken JA

Publikováno v: The Prostate [Prostate] 2010 Jan 01; Vol. 70 (1), pp. 10-6.